Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. - Wikidata - awgldk - TriplyDB

Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.

Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.

http://www.wikidata.org/entity/Q35592155

about

Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study Mechanistic Pathways of Sex Differences in Cardiovascular Disease.Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.Choline protects against cardiac hypertrophy induced by increased after-load.Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha.Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload.E2/ER β Enhances Calcineurin Protein Degradation and PI3K/Akt/MDM2 Signal Transduction to Inhibit ISO-Induced Myocardial Cell Apoptosis.Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts.Estrogen protects against intracranial aneurysm rupture in ovariectomized mice.Female rats with severe left ventricle volume overload exhibit more cardiac hypertrophy but fewer myocardial transcriptional changes than males.Influence of sex hormones and phytoestrogens on heart disease in men and women Potential phytoestrogen alternatives exert cardio-protective mechanisms via estrogen receptors PDE5 inhibitor efficacy is estrogen dependent in female heart disease.Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β.Mechanisms of right heart failure-A work in progress and a plea for failure prevention Effects of estrogen, an ERα agonist and raloxifene on pressure overload induced cardiac hypertrophy.Estrogen, hormonal replacement therapy and cardiovascular disease.Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8.Back to your heart: ubiquitin proteasome system-regulated signal transduction Methanolic Extract of Ceplukan Leaf (Physalis minima L.) Attenuates Ventricular Fibrosis through Inhibition of TNF-α in Ovariectomized Rats Estrogen signaling and cardiovascular disease.Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner Oestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy.CaMK4 Gene Deletion Induces Hypertension.Tropomyosin dephosphorylation results in compensated cardiac hypertrophy The estrogen receptor-α is required and sufficient to maintain physiological glucose uptake in the mouse heart.Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway.Calcineurin activity is required for cardiac remodelling in pregnancy Parsing good versus bad signaling pathways in the heart: role of calcineurin-nuclear factor of activated T-cells.Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women.Estrogen and the cardiovascular system.Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview.Sex steroids in relation to cardiac structure and function in men.Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats.Estradiol in vivo induces changes in cardiomyocytes size in obese rats.Sex differences in health and disease: brain and heart connections--a special issue.Does oestradiol attenuate the damaging effects of a fructose-rich diet on cardiac Akt/endothelial nitric oxide synthase signalling?Female ClockΔ19/Δ19 mice are protected from the development of age-dependent cardiomyopathy.

P2860

Q28388122-603CC584-A24E-493F-A2FA-BCE565F0F5EB Q30241924-5B721429-2C27-4355-8B2D-1002DFA703C0 Q30477731-8C01BFA6-15DA-496E-B0BF-083DB236B8E5 Q30537555-28D74A21-BCF0-406E-A132-EEFB95F4D112 Q31079547-B6792FDE-1EAA-483E-B70B-471AD7C4DA65 Q33550675-2492ECE6-D660-49D3-8BA0-86559402B811 Q33625017-F32313DF-E2FE-4105-B85B-58624AB7CB0F Q33651036-4C13292B-3ABA-4CED-94BA-8DEED0F3EDCD Q33655936-EBA1B0BE-9EC1-4CB3-8E04-22681FDEBC90 Q33667438-2F3CEE09-7EA0-49B3-878B-E075E9EF24CC Q33677908-36B9BAB3-3D45-41B8-89F0-9559EE8AABA0 Q33721061-2DFF2FE4-A719-44EC-B129-CDE1A39C5F5F Q33821464-995969F8-6D88-4608-9DE8-D1C27C2343DC Q33872491-F1EBA8D7-4876-4C90-9FBB-96F36C4B2EB7 Q34256551-73223154-7F8D-483C-BCD2-C83F576434A0 Q34343977-88525FE2-2E6D-4175-8C81-4256A87DD55C Q34507109-A8764557-9995-4B32-A6CD-63407906B1FC Q35070227-B5F04CB2-EB0C-44D7-B42F-8B217A7392D6 Q35543254-2140C0D4-ACA3-4CB2-B0C7-46AEEFA70526 Q35803035-C9878099-7381-4564-9CA3-24A411E6F183 Q35945725-54F3B6A2-359C-4A5E-8FD8-BF99AB4F612B Q36099354-3E0EF7FF-D8CB-4D6E-8E2A-59FD28714AA0 Q36177370-E8A59679-A6D9-4C85-904C-CAD1D9C292F7 Q36342177-C7C80AAA-E162-4481-A45C-341594F55873 Q36366241-1977B323-273E-489B-924F-B89CAFE7DB40 Q36492849-49F3A06C-9F86-4C97-8DF4-4F60BC825F59 Q36642013-77E6ACA9-BBEE-4FCD-831A-C64CEE7DA3F0 Q37286660-386F51CC-0146-4AB5-8F32-9BD196B9026F Q37305456-1DF86A35-CC86-4A1A-BF1A-512DF4F8FDFC Q37332613-C4DDE4E1-5BD5-4482-8C56-8C8F493FB345 Q37742603-7983E735-60A0-42BF-BE5A-FB9EB1548216 Q38000962-6954A930-89AD-47AE-A62B-B183B07C74A4 Q38702801-498580A0-8A2D-4F3E-8A4F-05220132C967 Q38727579-07CAE043-BDDA-48B6-A3F3-438FC45A88AA Q38822908-5B673F4F-1D6C-4AA9-A088-F6EBFD311963 Q39260216-A408324B-EEEC-4711-B616-DA62D486E02A Q43462526-3364E776-E912-4F49-BE93-0DC0DB979943 Q44568130-C4B09F38-DEFD-4667-962B-A2B042CAD679 Q45931829-DC65DAE8-D1FE-4E5D-9791-5FB86F7D2823 Q47634487-29CFF94C-2B84-415E-B7A6-FD24B96EE564

P2860

Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.

http://www.wikidata.org/entity/Q35592155

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Estrogen attenuates left ventr ...... eases calcineurin degradation.

@ast

Estrogen attenuates left ventr ...... eases calcineurin degradation.

@en

type

label

Estrogen attenuates left ventr ...... eases calcineurin degradation.

@ast

Estrogen attenuates left ventr ...... eases calcineurin degradation.

@en

prefLabel

Estrogen attenuates left ventr ...... eases calcineurin degradation.

@ast

Estrogen attenuates left ventr ...... eases calcineurin degradation.

@en

P1433

Q35592155-BB0D647B-22B2-4552-8A8B-4A803E071363

P1476

Q35592155-1987392B-9266-406B-B586-E3EA43F05A7F

P2093

Q35592155-0CC64303-2D6D-412F-A4D1-45C7A55F0FDC

Q35592155-15660814-C0D9-4661-B31D-E7A25C58DEA9

Q35592155-377237C7-80AB-4253-A3D8-C2DB53B680FE

Q35592155-393701EC-3B8A-4C67-8B08-F0F432181E0C

Q35592155-669363AC-87D6-4522-91FF-AB0CEC2F3F95

Q35592155-7C7B8821-7444-4E0D-909C-F66363100083

Q35592155-B046CE6A-3928-4B57-B6BD-35F87508BA80

Q35592155-B8A2E00B-AFC9-44F1-BAA5-1D055EB309E8

Q35592155-DA6A780F-F77D-4770-B738-C9BDF29D413B

Q35592155-F16F8E4B-0991-4B51-8834-6305132CA72B

P2860

Q35592155-0B080AFC-4830-4D1C-B652-C2422CFB8DC0

Q35592155-14384C4F-108A-460C-B6CA-455A8E662E11

Q35592155-1DEE35F5-F04F-4923-88B2-33D9CBDBE491

Q35592155-21AC10EF-A0D4-4590-BFFF-A79024F21C2B

Q35592155-24B661D3-78EA-4E1A-8FED-0E9FF2E530EA

Q35592155-2958A5C6-B382-485A-8A0D-D6D2198457B6

Q35592155-5112B28D-A4FA-4FC6-86D4-F7FE9D5050DB

Q35592155-5B86D3E2-2B9B-41A0-BDE9-C6DA2F6A2123

Q35592155-61886DF9-0A84-4CB8-B7E7-699AAFA6243B

Q35592155-7627077D-C3EC-4EE1-A2DD-1B0645F2E31A

P304

Q35592155-4AA74081-6F4B-4828-A671-469F3965BFC8

P31

Q35592155-744ACFDD-3493-42EC-86B4-B316D5D0FF0F

P356

Q35592155-1C844973-18D8-4FF3-AEBA-5456F069931B

P433

Q35592155-FE32209C-8B65-45A0-89C8-23BBFF43BA23

P478

Q35592155-26A42712-827E-44ED-A6FF-CEDDDB27FDB2

P50

Q35592155-13860873-0B20-4965-9C38-2B9CA2153D73

P577

Q35592155-2FB5E992-D4DF-49D7-BCF1-3B94F5D152FB

P698

Q35592155-3E9845A8-794B-463D-8515-6840E75D9858

P932

Q35592155-31A01DB3-09DC-40CA-A534-E8DA62E58C34

P356

CIRCRESAHA.108.190397

P1433

Circulation Research

P1476

Estrogen attenuates left ventr ...... eases calcineurin degradation.

@en

P2093

Adam Ackerman

http://www.w3.org/2001/XMLSchema#string

Alexandra Dabreo Weiss

http://www.w3.org/2001/XMLSchema#string

Cameron Donaldson

http://www.w3.org/2001/XMLSchema#string

Corey Baker

http://www.w3.org/2001/XMLSchema#string

Feng Wang

http://www.w3.org/2001/XMLSchema#string

Mark J Aronovitz

http://www.w3.org/2001/XMLSchema#string

Monica Hall-Porter

http://www.w3.org/2001/XMLSchema#string

Richard D Patten

http://www.w3.org/2001/XMLSchema#string

Richard H Karas

http://www.w3.org/2001/XMLSchema#string

Sarah Eder

http://www.w3.org/2001/XMLSchema#string

P2860

A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling

The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo

Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1

Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice

The roles of gender, the menopause and hormone replacement on cardiovascular function.

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Calcineurin and beyond: cardiac hypertrophic signaling.

Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

P304

265-75, 11p following 275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.108.190397

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Jeffery D. Molkentin

P577

2008-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19074476

http://www.w3.org/2001/XMLSchema#string

P932

4427027

http://www.w3.org/2001/XMLSchema#string